Ashland Q3 Earnings and Sales Lag Estimates, Guidance Narrowed

05.08.25 14:18 Uhr

Werte in diesem Artikel

Ashland Global Holdings Inc. ASH recorded a loss of $742 million or $16.21 per share in third-quarter fiscal 2025 (ended June 30) compared with a profit of $6 million or 12 cents in the prior-year quarter.Barring one-time items, adjusted earnings were $1.04 per share, down from the year-ago quarter’s figure of $1.49. The bottom line missed the Zacks Consensus Estimate of $1.15.Sales were down 14.9% year over year to $463 million. The top line missed the Zacks Consensus Estimate of $468.4 million. Sales for the fiscal third quarter were adversely impacted by the portfolio optimization actions involving curtailing or divesting certain lower-margin products, lower volumes in Specialty Additives and Personal Care, and reduced pricing in Life Sciences and Intermediates.Ashland Inc. Price, Consensus and EPS Surprise Ashland Inc. price-consensus-eps-surprise-chart | Ashland Inc. QuoteASH’s Segment HighlightsLife Sciences:Sales in the segment were down 17% year over year to $162 million in the reported quarter. The Zacks Consensus Estimate for the same was $170 million. The decline was primarily caused by the divestiture of the Neutraceuticals division and the exit of the low-margin nutrition offerings.Personal Care:Sales in the division declined 16% year over year to $147 million. The metric met the Zacks Consensus Estimate. The decrease was mostly due to portfolio optimization, mainly attributed to the divestiture of the Avoca business line.Specialty Additives:Sales in the segment fell 13% year over year to $131 million but beat the Zacks Consensus Estimate of $124 million. The decline was mostly due to the exit from the low-margin construction business to optimize the portfolio.Intermediates: Sales in the segment went down 8% year over year to $33 million. The figure also missed the consensus estimate of $34.8 million. The overall sales decreased, mostly due to lower prices.ASH’s FinancialsCash and cash equivalents were $207 million at the end of the quarter, up around 23.2% sequentially. Long-term debt was $1,382 million, up roughly 3.4% over the same time frame.ASH’s OutlookFor the full fiscal year, Ashland now expects sales to be in the range of $1.825-$1.85 billion and adjusted EBITDA to be $400-$410 million, narrowing from the previous estimate of $1.825-$1.9 billion and $400-$420 million, respectively.ASH’s Price PerformanceShares of Ashland have lost 42.5% in the past year compared with a 1.3% decline in the industry.Image Source: Zacks Investment ResearchASH’s Zacks Rank & Key PicksASH currently carries a Zacks Rank #5 (Strong Sell).Better-ranked stocks worth a look in the basic materials space include Royal Gold, Inc. RGLD, Lithium Americas Corp. LAC and MAG SilverCorp. MAG.Royal Gold is slated to report second-quarter results on Aug. 6. The Zacks Consensus Estimate for earnings is pegged at $1.70 per share. RGLD’s earnings beat the Zacks Consensus Estimate in each of the last four quarters, with the average surprise being 9%. Royal Gold flaunts a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.Lithium Americas is expected to report second-quarter results on Aug. 12. The Zacks Consensus Estimate for LAC’s second-quarter earnings is pegged at a loss of 4 cents per share, indicating year-over-year growth of 20%. Lithium Americas’ earnings beat the Zacks Consensus Estimate in one of the last four quarters but missed it in the rest. LAC currently carries a Zacks Rank #2 (Buy).MAG Silver is slated to report second-quarter results on Aug. 11. The consensus estimate for MAG’s earnings is pegged at 26 cents per share. MAG carries a Zacks Rank #2 at present. MAG Silver’s earnings beat the consensus estimate in three of the last four quarters, while missing it in one, with the average surprise being 2.01%.   Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent. Thousands have taken advantage of this opportunity.Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators, and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ashland Inc. (ASH): Free Stock Analysis Report Royal Gold, Inc. (RGLD): Free Stock Analysis Report MAG Silver Corporation (MAG): Free Stock Analysis Report Lithium Americas Corp. (LAC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Ashland Global und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Ashland Global

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ashland Global

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Ashland Global Holdings Inc

Wer­bung

Analysen zu Ashland Global Holdings Inc

DatumRatingAnalyst
29.03.2018Ashland Global OutperformBMO Capital Markets
31.01.2018Ashland Global NeutralMonness, Crespi, Hardt & Co.
16.05.2017Ashland Global BuyMonness, Crespi, Hardt & Co.
28.11.2016Ashland BuyDeutsche Bank AG
27.01.2016Ashland BuyMonness, Crespi, Hardt & Co.
DatumRatingAnalyst
29.03.2018Ashland Global OutperformBMO Capital Markets
16.05.2017Ashland Global BuyMonness, Crespi, Hardt & Co.
28.11.2016Ashland BuyDeutsche Bank AG
27.01.2016Ashland BuyMonness, Crespi, Hardt & Co.
23.09.2015Ashland BuyDeutsche Bank AG
DatumRatingAnalyst
31.01.2018Ashland Global NeutralMonness, Crespi, Hardt & Co.
04.01.2007Update Ashland Inc.: HoldMatrix Research
03.01.2007Update Ashland Inc.: HoldKeyBanc Capital Markets / McDonald
05.12.2006Update Ashland Inc.: NeutralJP Morgan
15.11.2006Update Ashland Inc.: NeutralCredit Suisse
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ashland Global Holdings Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen